Rate-dependent activation failure in isolated cardiac cells and tissue due to Na+ channel block

American Journal of Physiology. Heart and Circulatory Physiology
Anthony VargheseDenis Noble

Abstract

While it is well established that class-I antiarrhythmics block cardiac sodium channels, the mechanism of action of therapeutic levels of these drugs is not well understood. Using a combination of mathematical modeling and in vitro experiments, we studied the failure of activation of action potentials in single ventricular cells and in tissue caused by Na(+) channel block. Our computations of block and unblock of sodium channels by a theoretical class-Ib antiarrhythmic agent predict differences in the concentrations required to cause activation failure in single cells as opposed to multicellular preparations. We tested and confirmed these in silico predictions with in vitro experiments on isolated guinea-pig ventricular cells and papillary muscles stimulated at various rates (2-6.67 Hz) and exposed to various concentrations (5 × 10(-6) to 500 × 10(-6) mol/l) of lidocaine. The most salient result was that whereas large doses (5 × 10(-4) mol/l or higher) of lidocaine were required to inhibit action potentials temporarily in single cells, much lower doses (5 × 10(-6) mol/l), i.e., therapeutic levels, were sufficient to have the same effect in papillary muscles: a hundredfold difference. Our experimental results and mathematical an...Continue Reading

References

Nov 14, 1977·Biochimica Et Biophysica Acta·L M Hondeghem, B G Katzung
Jan 1, 1975·Progress in Biophysics and Molecular Biology·P J HunterD Noble
Jan 7, 1991·Journal of Theoretical Biology·J P Keener
Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Nov 1, 1989·Circulation Research·A O GrantC F Starmer
Feb 1, 1989·The American Journal of Physiology·R W JoynerT T Do
May 1, 1983·The Journal of General Physiology·B P BeanR W Tsien
Sep 1, 1981·The Journal of Physiology·A M BrownT Powell
Jul 1, 1996·Circulation Research·R H AnR S Kass
Mar 25, 2010·British Journal of Pharmacology·Hua Rong LuDavid J Gallacher
Jun 16, 2011·Nature Communications·Stephan A PlessChristopher A Ahern
Sep 3, 2011·Science Translational Medicine·Jonathan D MorenoColleen E Clancy
Apr 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Michelle L MilsteinJosé Jalife
Apr 3, 2014·Physiological Reviews·Nicole SchmittSøren-Peter Olesen

❮ Previous
Next ❯

Citations

Nov 30, 2016·Frontiers in Physiology·Anthony Varghese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.